| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Lundberg Laboratory for Diabetes Research (G.M., A.H., M.Sa., U.S., P.-A.J.), Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at Göteborg University, S-413 45 Göteborg, Sweden; Department of Internal Medicine (G.M.), Section of Internal Medicine, Endocrine and Metabolic Sciences, Perugia University, I-06122, Perugia, Italy; Department of Anesthesiology and Intensive Care Medicine Mannheim (M.Sc.), University of Heidelberg, 368 D-69120 Heidelberg, Germany; and German Diabetes Clinic (C.H.), German Diabetes Center, Leibniz Center at Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany
Address all correspondence and requests for reprints to: Giuseppe Murdolo, M.D., Ph.D., Department of Internal Medicine, Division of Endocrinology and Metabolism, Via Enrico Dal Pozzo, I-06122 Perugia, Italy. E-mail: giuseppe.murdolo{at}medic.gu.se; gmurdolo{at}tiscalinet.it.
Context: The chemokine monocyte chemoattractant protein-1 (MCP-1) is implicated in obesity-associated chronic inflammation, insulin resistance, and atherosclerosis.
Objectives: The objectives of this study were to: 1) characterize the interstitial levels and the gene expression of MCP-1 in the sc abdominal adipose tissue (SCAAT), 2) elucidate the response of MCP-1 to acute hyperinsulinemia, and 3) determine the relationship between MCP-1 and arterial stiffness.
Design: Nine lean (L) and nine uncomplicated obese (OB) males were studied in the fasting state and during a euglycemic-hyperinsulinemic clamp combined with the microdialysis technique. Interstitial and serum MCP-1 (iMCP-1 and sMCP-1, respectively) levels, pulse wave analysis, and SCAAT biopsies were characterized at baseline and after hyperinsulinemia.
Results: OB showed elevated sMCP-1 (P < 0.01) but similar iMCP-1 levels as compared with L. Basal iMCP-1 concentrations were considerably higher than sMCP-1 (P < 0.0001), and a gradient between iMCP-1 and sMCP-1 levels was maintained throughout the hyperinsulinemia. At baseline, SCAAT gene expression profile revealed a "co-upregulation" of MCP-1, MCP-2, macrophage inflammatory protein-1
, and CD68 in OB, and whole-body glucose disposal inversely correlated with the MCP-1 gene expression. After hyperinsulinemia, MCP-1 and MCP-2 mRNA levels significantly increased in L, but not in OB. Finally, sMCP-1 excess in the OB positively correlated with the stiffer vasculature.
Conclusions: These observations demonstrate similar interstitial concentrations and a differential gene response to hyperinsulinemia of MCP-1 in the SCAAT from L and OB individuals. In human obesity, we suggest the SCAAT MCP-1 gene overexpression as a biomarker of an "inflamed" adipose organ and impaired glucose metabolism.
This article has been cited by other articles:
![]() |
G. Murdolo, A. Hammarstedt, M. Schmelz, P.-A. Jansson, and U. Smith Acute Hyperinsulinemia Differentially Regulates Interstitial and Circulating Adiponectin Oligomeric Pattern in Lean and Insulin-Resistant, Obese Individuals J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4508 - 4516. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Siklova-Vitkova, J. Polak, E. Klimcakova, J. Vrzalova, J. Hejnova, M. Kovacikova, Z. Kovacova, M. Bajzova, L. Rossmeislova, Z. Hnevkovska, et al. Effect of hyperinsulinemia and very-low-calorie diet on interstitial cytokine levels in subcutaneous adipose tissue of obese women Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1154 - E1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ortega Martinez de Victoria, X. Xu, J. Koska, A. M. Francisco, M. Scalise, A. W. Ferrante Jr., and J. Krakoff Macrophage Content in Subcutaneous Adipose Tissue: Associations With Adiposity, Age, Inflammatory Markers, and Whole-Body Insulin Action in Healthy Pima Indians Diabetes, February 1, 2009; 58(2): 385 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Murdolo, C. Herder, Z. Wang, B. Rose, M. Schmelz, and P.-A. Jansson In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1095 - E1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Mallewa, E. Wilkins, J. Vilar, M. Mallewa, D. Doran, D. Back, and M. Pirmohamed HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options J. Antimicrob. Chemother., October 1, 2008; 62(4): 648 - 660. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |